-
AFFORDABILITY OF NOVEL DISEASE-MODIFYING THERAPIES: TAFAMIDIS AND ATTR-CM
Mar 18, 2026, 21:38 PM -
FROM TEXT TO SIGNAL: EVALUATING LLMS FOR VALID CASE IDENTIFICATION IN PHARMACOVIGILANCE
Mar 18, 2026, 21:38 PM -
REAL-WORLD UTILIZATION-INFORMED, ROUTE-STRATIFIED OPTIMIZATION OF IVIG/SCIG SELECTION TO IMPROVE INFUSION-CENTER THROUGHPUT
Mar 18, 2026, 21:38 PM -
MEASURING FUNCTIONAL ABILITIES AND ASSISTANCE LEVEL IN NIEMANN-PICK DISEASE TYPE C AND GM2 GANGLIOSIDOSES
Mar 18, 2026, 21:38 PM -
OBSERVED CARDIOVASCULAR DISEASE PREVALENCE AMONG OBESE AND TYPE 2 DIABETES PATIENTS WITH AND WITHOUT GLP-1 TREATMENT
Mar 18, 2026, 21:38 PM -
IMPLEMENTATION PROGRESS OF THE COUVERTURE MALADIE UNIVERSELLE IN COTE D'IVOIRE: INSIGHT FROM A RAPID REVIEW OF HEALTH FINANCING AND POLICY APPROACHES
Mar 18, 2026, 21:38 PM -
POST-MARKETING SAFETY PROFILE OF ANTIDEPRESSANTS IN 2013 TO 2025
Mar 18, 2026, 21:38 PM -
PATIENT JOURNEY FOUNDATIONAL MODEL FOR SCALABLE IMPUTATION OF MISSING UNITS OF MEASUREMENT (UOM) IN ELECTRONIC HEALTH RECORDS DATA
Mar 18, 2026, 21:38 PM -
POWER, POLITICS, AND PRICE: GOVERNANCE FAILURES IN NEPAL’S PHARMACEUTICAL SYSTEM AND THE UHC CHALLENGE
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS
Mar 18, 2026, 21:38 PM -
DEMOGRAPHIC DISPARITIES IN HPV VACCINE INITIATION AMONG KENTUCKY MEDICAID BENEFICIARIES
Mar 18, 2026, 21:38 PM -
WHAT HTA BODIES CRITICIZE IN INDIRECT TREATMENT COMPARISONS FOR ADVANCED CANCERS: A THEMATIC ANALYSIS OF RECENT HTA REPORTS IN SOLID TUMORS
Mar 18, 2026, 21:38 PM -
AN INDIRECT TREATMENT COMPARISON (ITC) OF IFINATAMAB DERUXTECAN (I-DXD) VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY (RWPCT) IN PATIENTS PREVIOUSLY TREATED WITH AT LEAST 2 LINES OF THERAPY (LOTS) FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER...
Mar 18, 2026, 21:38 PM -
FAST&FURIOUSHEOR IMPACT:THE AI ASSISTANT PLAYBOOKTO BUILDTRUSTAND RESILIENCYINTHEFAST-PACED WORLD OFLARGE LANGUAGE MODELS (LLMS)
Mar 18, 2026, 21:38 PM -
VALIDATION EVIDENCE OF HEALTHCARE UTILISATION MEASURES FOR PAEDIATRIC POPULATIONS: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
PSYCHOTROPIC MEDICATIONS USE AND HIP FRACTURE RISK IN COMMUNITY-DWELLING OLDER ADULTS: A NESTED KNOWLEDGE ASSISTED META-ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF FIXED-DOSE SUBCUTANEOUS PERTUZUMAB-TRASTUZUMAB FOR NEOADJUVANT TREATMENT OF HIGH-RISK HER2-POSITIVE EARLY BREAST CANCER IN INDONESIA
Mar 18, 2026, 21:38 PM -
CARDIOVASCULAR RISK STRATIFICATION USING UNSUPERVISED MACHINE LEARNING IN BREAST CANCER PATIENTS, INITIATING ANTHRACYCLINE-BASED TREATMENTS
Mar 18, 2026, 21:38 PM -
ALGORITHMIC FAIRNESS IN MACHINE LEARNING PREDICTION FOR LONG-TERM ADJUVANT ENDOCRINE THERAPY ADHERENCE AMONG BREAST CANCER SURVIVORS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN US PLATINUM-RESISTANT OVARIAN CANCER PATIENTS: CHARACTERIZING THE UNMET CLINICAL NEED
Mar 18, 2026, 21:38 PM
